Montag & Associates’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-986
| Closed | -$65.9K | – | 1024 |
|
|
2024
Q3 | $65.9K | Sell |
986
-300
| -23% | -$20K | ﹤0.01% | 555 |
|
|
2024
Q2 | $153K | Sell |
1,286
-100
| -7% | -$11.9K | 0.01% | 441 |
|
|
2024
Q1 | $148K | Sell |
1,386
-41
| -3% | -$4.37K | 0.01% | 447 |
|
|
2023
Q4 | $142K | Sell |
1,427
-865
| -38% | -$86K | 0.01% | 438 |
|
|
2023
Q3 | $237K | Sell |
2,292
-400
| -15% | -$41.3K | 0.01% | 364 |
|
|
2023
Q2 | $327K | Sell |
2,692
-2,747
| -51% | -$334K | 0.02% | 339 |
|
|
2023
Q1 | $835K | Buy |
5,439
+323
| +6% | +$49.6K | 0.05% | 230 |
|
|
2022
Q4 | $919K | Buy |
5,116
+3,315
| +184% | +$595K | 0.06% | 211 |
|
|
2022
Q3 | $213K | Sell |
1,801
-1,299
| -42% | -$154K | 0.01% | 345 |
|
|
2022
Q2 | $443K | Sell |
3,100
-6,856
| -69% | -$980K | 0.03% | 277 |
|
|
2022
Q1 | $1.72M | Sell |
9,956
-154
| -2% | -$26.5K | 0.09% | 182 |
|
|
2021
Q4 | $2.57M | Sell |
10,110
-4,489
| -31% | -$1.14M | 0.13% | 155 |
|
|
2021
Q3 | $5.62M | Sell |
14,599
-6,190
| -30% | -$2.38M | 0.3% | 92 |
|
|
2021
Q2 | $4.89M | Buy |
20,789
+763
| +4% | +$179K | 0.26% | 101 |
|
|
2021
Q1 | $2.62M | Buy |
20,026
+18,526
| +1,235% | +$2.43M | 0.15% | 145 |
|
|
2020
Q4 | $157K | Buy |
+1,500
| New | +$157K | 0.01% | 397 |
|